Literature DB >> 24114474

The diet as a cause of human prostate cancer.

William G Nelson1, Angelo M Demarzo, Srinivasan Yegnasubramanian.   

Abstract

Asymptomatic prostate inflammation and prostate cancer have reached epidemic proportions among men in the developed world. Animal model studies implicate dietary carcinogens, such as the heterocyclic amines from over-cooked meats and sex steroid hormones, particularly estrogens, as candidate etiologies for prostate cancer. Each acts by causing epithelial cell damage, triggering an inflammatory response that can evolve into a chronic or recurrent condition. This milieu appears to spawn proliferative inflammatory atrophy (PIA) lesions, a type of focal atrophy that represents the earliest of prostate cancer precursor lesions. Rare PIA lesions contain cells which exhibit high c-Myc expression, shortened telomere segments, and epigenetic silencing of genes such as GSTP1, encoding the π-class glutathione S-transferase, all characteristic of prostatic intraepithelial neoplasia (PIN) and prostate cancer. Subsequent genetic changes, such as the gene translocations/deletions that generate fusion transcripts between androgen-regulated genes (such as TMPRSS2) and genes encoding ETS family transcription factors (such as ERG1), arise in PIN lesions and may promote invasiveness characteristic of prostatic adenocarcinoma cells. Lethal prostate cancers contain markedly corrupted genomes and epigenomes. Epigenetic silencing, which seems to arise in response to the inflamed microenvironment generated by dietary carcinogens and/or estrogens as part of an epigenetic "catastrophe" affecting hundreds of genes, persists to drive clonal evolution through metastatic dissemination. The cause of the initial epigenetic "catastrophe" has not been determined but likely involves defective chromatin structure maintenance by over-exuberant DNA methylation or histone modification. With dietary carcinogens and estrogens driving pro-carcinogenic inflammation in the developed world, it is tempting to speculate that dietary components associated with decreased prostate cancer risk, such as intake of fruits and vegetables, especially tomatoes and crucifers, might act to attenuate the ravages of the chronic or recurrent inflammatory processes. Specifically, nutritional agents might prevent PIA lesions or reduce the propensity of PIA lesions to suffer "catastrophic" epigenome corruption.

Entities:  

Mesh:

Year:  2014        PMID: 24114474      PMCID: PMC4486067          DOI: 10.1007/978-3-642-38007-5_4

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


  96 in total

1.  Formation and stability of heterocyclic amines in a meat flavour model system. Effect of temperature, time and precursors.

Authors:  M Bordas; E Moyano; L Puignou; M T Galceran
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2004-03-25       Impact factor: 3.205

2.  Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States.

Authors:  W Haenszel; M Kurihara
Journal:  J Natl Cancer Inst       Date:  1968-01       Impact factor: 13.506

3.  Prepubertal exposure to compounds that increase prolactin secretion in the male rat: effects on the adult prostate.

Authors:  T E Stoker; C L Robinette; B H Britt; S C Laws; R L Cooper
Journal:  Biol Reprod       Date:  1999-12       Impact factor: 4.285

4.  Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study.

Authors:  S Lilly Zheng; Katarina Augustsson-Bälter; Baoli Chang; Maria Hedelin; Liwu Li; Hans-Olov Adami; Jeanette Bensen; Ge Li; Jan-Erik Johnasson; Aubrey R Turner; Tamara S Adams; Deborah A Meyers; William B Isaacs; Jianfeng Xu; Henrik Grönberg
Journal:  Cancer Res       Date:  2004-04-15       Impact factor: 12.701

5.  Cruciferous vegetable consumption alters the metabolism of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in humans.

Authors:  David G Walters; Philip J Young; Cynthia Agus; Mark G Knize; Alan R Boobis; Nigel J Gooderham; Brian G Lake
Journal:  Carcinogenesis       Date:  2004-04-08       Impact factor: 4.944

6.  Suppression of N-methyl-N-nitrosourea/testosterone-induced rat prostate cancer growth by celecoxib: effects on cyclooxygenase-2, cell cycle regulation, and apoptosis mechanism(s).

Authors:  Bhagavathi A Narayanan; Mark S Condon; Maarten C Bosland; Narayanan K Narayanan; Bandaru S Reddy
Journal:  Clin Cancer Res       Date:  2003-08-15       Impact factor: 12.531

7.  Hypermethylation of CpG islands in primary and metastatic human prostate cancer.

Authors:  Srinivasan Yegnasubramanian; Jeanne Kowalski; Mark L Gonzalgo; Marianna Zahurak; Steven Piantadosi; Patrick C Walsh; G Steven Bova; Angelo M De Marzo; William B Isaacs; William G Nelson
Journal:  Cancer Res       Date:  2004-03-15       Impact factor: 12.701

8.  The aging ACI/Seg versus Copenhagen male rat as a model system for the study of prostatic carcinogenesis.

Authors:  J T Isaacs
Journal:  Cancer Res       Date:  1984-12       Impact factor: 12.701

9.  Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2',5'-oligoadenylates.

Authors:  Ying Xiang; Zhengfu Wang; Junko Murakami; Sarah Plummer; Eric A Klein; John D Carpten; Jeffrey M Trent; William B Isaacs; Graham Casey; Robert H Silverman
Journal:  Cancer Res       Date:  2003-10-15       Impact factor: 12.701

Review 10.  Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis.

Authors:  S Mahmud; E Franco; A Aprikian
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

View more
  11 in total

1.  Association of interleukin-6 (-174 G/C) polymorphism with the prostate cancer risk: A meta-analysis.

Authors:  Mingyuan Yang; Chao Li; Ming Li
Journal:  Biomed Rep       Date:  2014-06-16

2.  GSTP1 Loss results in accumulation of oxidative DNA base damage and promotes prostate cancer cell survival following exposure to protracted oxidative stress.

Authors:  Omar Y Mian; Mohamed H Khattab; Mohammad Hedayati; Jonathan Coulter; Budri Abubaker-Sharif; Julie M Schwaninger; Ravi K Veeraswamy; James D Brooks; Lisa Hopkins; Debika Biswal Shinohara; Brian Cornblatt; William G Nelson; Srinivasan Yegnasubramanian; Theodore L DeWeese
Journal:  Prostate       Date:  2015-10-08       Impact factor: 4.104

3.  A randomized trial of diet in men with early stage prostate cancer on active surveillance: rationale and design of the Men's Eating and Living (MEAL) Study (CALGB 70807 [Alliance]).

Authors:  J Kellogg Parsons; John P Pierce; James Mohler; Electra Paskett; Sin-Ho Jung; Peter Humphrey; John R Taylor; Vicky A Newman; Leslie Barbier; Cheryl L Rock; James Marshall
Journal:  Contemp Clin Trials       Date:  2014-05-13       Impact factor: 2.226

4.  Poultry consumption and prostate cancer risk: a meta-analysis.

Authors:  Qian He; Zheng-Ce Wan; Xiao-Bing Xu; Jing Wu; Guang-Lian Xiong
Journal:  PeerJ       Date:  2016-02-02       Impact factor: 2.984

5.  New insights into the effects of onion consumption on lipid mediators using a diet-induced model of hypercholesterolemia.

Authors:  Diana González-Peña; Antonio Checa; Begoña de Ancos; Craig E Wheelock; Concepción Sánchez-Moreno
Journal:  Redox Biol       Date:  2016-12-09       Impact factor: 11.799

Review 6.  Association between polymorphic CAG repeat lengths in the androgen receptor gene and susceptibility to prostate cancer: A systematic review and meta-analysis.

Authors:  Zhiqiang Qin; Xiao Li; Peng Han; Yuxiao Zheng; Hanyu Liu; Jingyuan Tang; Chengdi Yang; Jianzhong Zhang; Kunpeng Wang; Xiaokang Qi; Min Tang; Wei Wang; Wei Zhang
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

7.  Evolution: Back to the future to understand and control prostate cancer.

Authors:  Donald S Coffey
Journal:  Asian J Urol       Date:  2015-04-16

8.  Age-Specific Serum Total and Free Estradiol Concentrations in Healthy Men in US Nationally Representative Samples.

Authors:  Susan Chadid; John R Barber; Sabine Rohrmann; William G Nelson; James D Yager; Norma F Kanarek; Gary Bradwin; Adrian S Dobs; Katherine A McGlynn; Elizabeth A Platz
Journal:  J Endocr Soc       Date:  2019-07-19

Review 9.  Linking obesogenic dysregulation to prostate cancer progression.

Authors:  Renea A Taylor; Jennifer Lo; Natasha Ascui; Matthew J Watt
Journal:  Endocr Connect       Date:  2015-12       Impact factor: 3.335

10.  Do Exposure to Arsenic, Occupation and Diet Have Synergistic Effects on Prostate Cancer Risk?

Authors:  María Dolores Román; Camila Niclis; Laura Rosana Aballay; María Josefina Lantieri; María Dِel Pilar Díaz; Sonia Edith Muñoz
Journal:  Asian Pac J Cancer Prev       Date:  2018-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.